Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Needham Maintains Buy on Gamida Cell, Lowers Price Target to $9

Needham analyst Gil Blum maintains Gamida Cell (NASDAQ:GMDA) with a Buy and lowers the price target from $12 to $9.
byBenzinga Newsdesk
September 29, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Needham analyst Gil Blum maintains Gamida Cell (NASDAQ:GMDA) with a Buy and lowers the price target from $12 to $9.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts